The long-term consequences of sulfur mustard on Iranian chemical victims: Introduction

Toxin Reviews

Volumn 28, Issue 1, 2009, Pages 1-2

  Ghazanfari, Tooba ^a   Mohammad Hassan, Zuhair ^b   Foroutan, Abbas ^c  

^a SHAHED UNIVERSITY   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

MUSTARD GAS;

ARTICLE; BLOOD TOXICITY; CARDIOVASCULAR DISEASE; CHEMICAL WARFARE; ENVIRONMENTAL EXPOSURE; EYE TOXICITY; HUMAN; IRAN; LIFESTYLE; LUNG TOXICITY; RHEUMATIC DISEASE; SKIN TOXICITY; VICTIM;

EID: 70350573324     PISSN: 15569543     EISSN: 15569551     Source Type: Journal    
DOI: 10.1080/15569540802689022     Document Type: Article

References (27)

1. Balali-Mood M, Hefazi M. (2005). The pharmacology, toxicology, and medical treatment of sulphur mustard poisoning. Fundam Clin Pharmacol 19:297-315.
2. Balali-Mood M, Hefazi M, Mahmoudi M, Jalali E, Attaran D, Maleki M, et al. (2005). Long-term complications of sulphur mustard poisoning in severely intoxicated Iranian veterans. Fundam Clin Pharmacol 19:713-721.
3. Bignold LP. (2006). Alkylating agents and DNA polymerases. Anticancer Res 26:1327-1336.
4. Bijani K, Moghadamnia AA. (2002). Long-term effects of chemical weapons on respiratory tract in Iraq-Iran war victims living in Babol (North of Iran). Ecotoxicol Environ Saf 53:422-424.
5. Bullman T, Kang H. (2000). A fifty year mortality follow-up study of veterans exposed to low level chemical warfare agent, mustard gas. Ann Epidemiol 10:333-338.
6. Emad A, Emad V. (2007a). Elevated levels of MCP-1, MIP-[alpha] and MIP-1[beta] in the bronchoalveolar lavage (BAL) fluid of patients with mustard gas-induced pulmonary fibrosis. Toxicology 240:60-69.
7. Emad A, Emad Y. (2007b). Increased in CD8 T lymphocytes in the BAL fluid of patients with sulfur mustard gasinduced pulmonary fibrosis. Resp Med 101:786-792.
8. Emad A, Rezaian GR. (1997). The diversity of the effects of sulfur mustard gas inhalation on respiratory system 10 years after a single, heavy exposure: analysis of 197 cases. Chest 112 (3):734-738.
9. Emad A, Rezaian GR. (1999a). Characteristics of bronchoalveolar lavage fluid in patients with sulfur mustard gas-induced asthma or chronic bronchitis. Am J Med 106:625-628.
10. Emad A, Rezaian GR. (1999b). Immunoglobulins and cellular constituents of the BAL fluid of patients with sulfur mustard gas-induced pulmonary fibrosis. Chest 115:1346-1351.
11. Emadi SN, Hosseini-Khalili A, Soroush MR, Davoodi SM, Aghamiri SS. (2008). Mustard gas scarring with specific pigmentary, trophic and vascular characteristics (case report, 16-year post-exposure). Ecotoxicol Environ Saf 69:574-576.
12. Evison D, Hinsley D, Rice P. (2002). Chemical weapons. BMJ 324:332-335.
13. Firooz, A, Komeili A, Dowlati Y. (1999). Eruptive melanocytic nevi and cherry angiomas secondary to exposure to sulfur mustard gas. J Am Acad Dermatol 40 (4):646-647.
14. Foroutan A. (2003). Medical Experiences of Iraq's Chemical Warfare. Tehran: Baqiyatallah Medical Sciences University, pp. 179-188.
15. Ghanei M, Aslani J, Khateri S, Hamadanizadeh K. (2003). Public health status of the civil population of Sardasht 15 years following large-scale wartime exposure to sulfur mustard. J Burns Wounds 2:7-18.
16. Ghanei M, Harandi AA. (2007). Long term consequences from exposure to sulfur mustard: a review. Inha. Toxicol 19:451-456.
17. Ghazanfari T, Faghihzadeh S, Aragizadeh H, Soroush MR, Yaraee R, Hassan ZM, et al. (2009) Sardasht-Iran Cohort Study of Chemical Warfare Victims: Design and Methods, Arch Iranian Med 12 (1): 5-14.
18. Ghasemi H, Ghazanfari T, Babaei M, Soroush MR, Yaraee R, Ghassemi-Broumand M, et al. (2008), Long-term ocular complications of sulfur mustard in the civilian victims of Sardasht, Iran, Cutaneous and Ocular Toxicology 27:4, 317-326.
19. Hassan ZM, Ebtekar M, Ghanei M, Taghikhani M, Noori Daloii MR, Ghazanfari T. (2006). Immunobiological consequences of sulfur mustard contamination. Iran J Allergy Asthma Immunol. 5:101-108.
20. Javadi MA, Yazdani S, Sajjadi H, Jadidi K, Karimian F, Einollahi B, Ja'farinasab MR, Zare M. (2005). Chronic and delayed-onset mustard gas keratitis: report of 48 patients and review of literature. Ophthalmology 112:617-625.
21. Javadi MA, Yazdani S, Kanavi MR, Mohammadpour M, Baradaran-Rafiee A, Jafarinasab MR, Einollahi B, Karimian F, Zare M, Naderi M, Rabei HM. (2007). Long-term outcomes of penetrating keratoplasty in chronic and delayed mustard gas keratitis. Cornea 26:1074-1078.
22. Khateri, S, Ghanei M, Keshavarz S, Soroush M, Haines D. (2003). Incidence of lung, eye, and skin lesions as late complications in 34,000 Iranians with wartime exposure to mustard agent. J Occup Environ Med 45:1136-1143.
23. Khateri S, Ghanei M, Soroush M, Haines D. (2005). Effect of mustard gas exposure in pediatric patients: long-term health status of mustard-exposed children, 14 years after chemical bombardment of Sardasht. Sofia: Publishing House of the Union of Scientists in Bulgaria.
24. Kehe K, Szinicz L. (2005). Medical aspects of sulphur mustard poisoning. Toxicology 214:198-209.
25. Mahmoudi M, Hefazi M, Rastin M, Balali-Mood M. (2005). Long-term hematological and immunological complications of sulfur mustard poisoning in Iranian veterans. Int Immunopharmacol 5:1479-1485.
26. Momeni AZ, Enshaeih S, Meghdadi M, Amindjavaheri M. (1992). Skin manifestations of mustard gas: a clinical study of 535 patients exposed to mustard gas. Arch. Dermatol. 128:775-780.
27. Zarchi K, Akbar A, Naieni KH. (2004). Long-term pulmonary complications in combatants exposed to mustard gas: a historical cohort study. Int. J. Epidemiol. 33:579-581.